Evidence map›Paper›PMID 41758199›Full record

ArticleLab on a chip2026

Vector-free DNA transfection by nuclear envelope mechanoporation.

Leyla Akh, Apresio K Fajrial, Sunwoo Sohn, Benjamin Seelbinder, Xin Xu, Wei Tan, Jill E Slansky, Corey P Neu, Xiaoyun Ding

Abstract read
In one paragraph

Article in Lab on a chip, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Leyla AkhBiomedical Engineering Program, University of Colorado, Boulder, CO 80309, USA. xiaoyun.ding@colorado.edu.ORCID 0000-0001-9308-6090
Apresio K FajrialPaul M. Rady Department of Mechanical Engineering, University of Colorado, Boulder, CO 80309, USA.ORCID 0000-0001-8946-6648
Sunwoo SohnPaul M. Rady Department of Mechanical Engineering, University of Colorado, Boulder, CO 80309, USA.
Benjamin SeelbinderPaul M. Rady Department of Mechanical Engineering, University of Colorado, Boulder, CO 80309, USA.
Xin XuPaul M. Rady Department of Mechanical Engineering, University of Colorado, Boulder, CO 80309, USA.
Wei TanBiomedical Engineering Program, University of Colorado, Boulder, CO 80309, USA. xiaoyun.ding@colorado.edu.
Jill E SlanskyDepartment of Immunology & Microbiology, University of Colorado Anschutz School of Medicine, Aurora, CO 80045, USA.ORCID 0000-0003-3820-1724
Corey P NeuBiomedical Engineering Program, University of Colorado, Boulder, CO 80309, USA. xiaoyun.ding@colorado.edu.
Xiaoyun DingBiomedical Engineering Program, University of Colorado, Boulder, CO 80309, USA. xiaoyun.ding@colorado.edu.ORCID 0000-0003-4252-9335

Funding

Cell membrane disruption and recovery for intracellular deliveryR35GM142817 · NIGMS · UNIVERSITY OF COLORADO · PI DING, XIAOYUN · 2021 to 2025
$1.8M
FACSAria Fusion Cell SorterS10OD021601 · OD · UNIVERSITY OF COLORADO · PI LIU, XUEDONG · 2016 to 2016
$599k
NIGMS NIH HHS R35 GM142817NIH HHS S10 OD021601
6 · The paper itself

Abstract

Genetic engineering of cells has a range of applications in treating incurable diseases. Plasmid DNA is a popular choice of nucleic acid for cell engineering due to its low cost and stability. However, plasmid DNA must survive the protective mechanisms present in the cell's cytoplasm to enter the nucleus for translation. Many of the existing methods for nucleic acid delivery, such as chemical-based and virus-based delivery, suffer from drawbacks induced by the nucleic acid carrier itself. Mechanical methods present an alternative to nucleic acid carriers by physically producing openings in the cell to deliver cargos. However, in most systems, the cell membrane openings are too small to deliver large cargos, or the poration process leads to low cell viability. In this study, we present a microfluidic device with integrated high aspect ratio nanostructures that repeatably rupture the cell membrane and nuclear envelope. These sharp-tipped nanolancets penetrate the cell deep enough to allow direct delivery of cargos into the nucleus, but still allow for cell recovery after treatment. We show the device's ability to deliver cargo to a variety of cell types while maintaining high viability. Then, we demonstrate the rapid onset of plasmid DNA expression that results from direct nuclear delivery of naked DNA, showing expression speeds comparable to microinjection, but with significantly greater throughput. We envision the use of this device as a tool to quickly produce high quantities of genetically engineered cells to treat a myriad of diseases.

Indexed as

DNALab-On-A-Chip DevicesNuclear EnvelopeTransfectionAnimalsCell SurvivalHumansPlasmidsDNA

Identifiers

PMID41758199
PMCPMC12947894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.